1. ICH, Q1A(R2), Stability testing of new drug substances and products (2003).
2. ICH, Q3B(R2), Impurities in new drug products (2006).
3. FDA, Code of Federal Regulations, Title 21, Section 211, Current good manufacturing practice for finished pharmaceuticals (Rockville, MD, 2012).
4. The role of analytical chemistry in drug-stability studies;Görög;Trends Anal. Chem.,2013
5. U.S. Pharmacopeial Convention, new chapter 1224, 1225, 1226, USP panel expert.